Each chewable tablet contains:

Zemethis® 15 mg: Maropitant (as maropitant citrate) 15 mg.

Zemethis® 30 mg: Maropitant (as maropitant citrate) 30 mg.

Zemethis® 60 mg: Maropitant (as maropitant citrate) 60 mg.

Zemethis® 120 mg: Maropitant (as maropitant citrate) 120 mg.

For the treatment and prevention of chemotherapy-induced nausea; prevention of vomiting except for that induced by motion sickness (sickness); prevention and treatment of vomiting, in combination with other adjunctive measures; prevention of perioperative nausea and vomiting and improvement in recovery from general anesthesia after the use of morphine, a μ-opioid receptor agonist.

Oral route. Prevention of motion sickness: 8 mg/kg (the tablet can be split for greater dosage accuracy). Zemethis® 15 mg: Chemotherapy-related vomiting and other vomiting: Minimum dose of 2 mg/kg (1 tablet for dogs weighing 3.75–7.5 kg). Zemethis® 30 mg: Chemotherapy-related vomiting and other vomiting: Minimum dose of 2 mg/kg (1 tablet for dogs weighing 7.5–15 kg). Zemethis® 60 mg: Chemotherapy-related vomiting and other vomiting: Minimum dose of 2 mg/kg (1 tablet for dogs weighing 15–30 kg). Zemethis® 120 mg: Chemotherapy-related vomiting and other vomiting: Minimum dose of 2 mg/kg (1 tablet for dogs weighing 30–60 kg).

Box of 1 or 4 soft chewable tablets in sealed aluminum blister pack of 1 g., Box of 1 or 4 soft chewable tablets in sealed aluminum blister pack of 2 g.,